[
  {
    "ts": "2025-10-31T21:12:27+00:00",
    "headline": "Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come",
    "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-amazon-stock-soars-apple-pares-gains-with-earnings-from-ai-players-to-come-211227493.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "035a1404-14a9-4292-96b8-08cca27526ee",
      "content": {
        "id": "035a1404-14a9-4292-96b8-08cca27526ee",
        "contentType": "STORY",
        "title": "Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come",
        "description": "",
        "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
        "pubDate": "2025-10-31T21:12:27Z",
        "displayTime": "2025-10-31T21:12:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/16eae3d0-b665-11f0-9adf-c9b02347c0dc",
          "originalWidth": 8192,
          "originalHeight": 5464,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PAdBcZfvqFeFlLBvuHCPsw--~B/aD01NDY0O3c9ODE5MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/16eae3d0-b665-11f0-9adf-c9b02347c0dc.cf.webp",
              "width": 8192,
              "height": 5464,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Du6MqQ2hszWnX3zvuYefIQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/16eae3d0-b665-11f0-9adf-c9b02347c0dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-amazon-stock-soars-apple-pares-gains-with-earnings-from-ai-players-to-come-211227493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-amazon-stock-soars-apple-pares-gains-with-earnings-from-ai-players-to-come-211227493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "WEN"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "SBUX"
            },
            {
              "symbol": "VZ"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "COIN"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "ARM"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "CAT"
            },
            {
              "symbol": "NOW"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SNAP"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "XYZ"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "7203.T"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "APP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T22:44:00+00:00",
    "headline": "Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal",
    "summary": "The lawsuit says Novo Nordisk’s offer for drug startup Metsera isn’t reasonably likely to be completed.",
    "url": "https://www.wsj.com/health/pharma/pfizer-sues-seeking-to-block-novo-nordisks-effort-to-undo-weight-loss-drug-deal-929710b2?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "c9257efb-acb8-3726-93cd-b54eaaf5012d",
      "content": {
        "id": "c9257efb-acb8-3726-93cd-b54eaaf5012d",
        "contentType": "STORY",
        "title": "Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal",
        "description": "",
        "summary": "The lawsuit says Novo Nordisk’s offer for drug startup Metsera isn’t reasonably likely to be completed.",
        "pubDate": "2025-10-31T22:44:00Z",
        "displayTime": "2025-10-31T22:44:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/c9257efb-acb8-3726-93cd-b54eaaf5012d/pfizer-sues-seeking-to-block.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/c559d1ff4a39beedce15aa75a1cc824f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1kEX7MreIo3Az2gEeMq8ug--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/c559d1ff4a39beedce15aa75a1cc824f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Br310NlKz0eImHhIOiUC_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/c559d1ff4a39beedce15aa75a1cc824f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/pfizer-sues-seeking-to-block-novo-nordisks-effort-to-undo-weight-loss-drug-deal-929710b2?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T22:24:00+00:00",
    "headline": "Metsera Issues Statement in Response to Litigation",
    "summary": "Metsera, Inc. (NASDAQ: MTSR) (\"Metsera\" or the \"Company\") today issued the following statement in response to litigation filed against the Company by Pfizer:",
    "url": "https://finance.yahoo.com/news/metsera-issues-statement-response-litigation-222400211.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "23d66937-302f-3577-999b-9b2298062cce",
      "content": {
        "id": "23d66937-302f-3577-999b-9b2298062cce",
        "contentType": "STORY",
        "title": "Metsera Issues Statement in Response to Litigation",
        "description": "",
        "summary": "Metsera, Inc. (NASDAQ: MTSR) (\"Metsera\" or the \"Company\") today issued the following statement in response to litigation filed against the Company by Pfizer:",
        "pubDate": "2025-10-31T22:24:00Z",
        "displayTime": "2025-10-31T22:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/a7ebbe3ef04b2db92c9db0f8cf892a0f",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s6XwiYr9g5PKDM7_uFCmWQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a7ebbe3ef04b2db92c9db0f8cf892a0f.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/31mKvCYuXCtxthWMRPfkqg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a7ebbe3ef04b2db92c9db0f8cf892a0f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-issues-statement-response-litigation-222400211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-issues-statement-response-litigation-222400211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T21:28:10+00:00",
    "headline": "Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk",
    "summary": "Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera.  New York-based Pfizer said Friday after markets closed that it was suing Metsera and a third drugmaker, Denmark’s Novo Nordisk, over a bid for Metsera that Novo announced Thursday.",
    "url": "https://finance.yahoo.com/news/pfizer-sues-stop-rival-bid-212810334.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "708225f4-1a72-3e15-83b0-42dcc38c9118",
      "content": {
        "id": "708225f4-1a72-3e15-83b0-42dcc38c9118",
        "contentType": "STORY",
        "title": "Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk",
        "description": "",
        "summary": "Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera.  New York-based Pfizer said Friday after markets closed that it was suing Metsera and a third drugmaker, Denmark’s Novo Nordisk, over a bid for Metsera that Novo announced Thursday.",
        "pubDate": "2025-10-31T21:28:10Z",
        "displayTime": "2025-11-01T11:42:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ap_finance_articles_694/e16e1765f50b475d28fd1db76932b54d",
          "originalWidth": 6000,
          "originalHeight": 4000,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9XIVajAlVaJXTsi30S4o6Q--~B/aD00MDAwO3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/ap_finance_articles_694/e16e1765f50b475d28fd1db76932b54d.cf.webp",
              "width": 6000,
              "height": 4000,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WeKgMKIvZyNvrBJJz0gAJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ap_finance_articles_694/e16e1765f50b475d28fd1db76932b54d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-sues-stop-rival-bid-212810334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-sues-stop-rival-bid-212810334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T21:26:53+00:00",
    "headline": "Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal",
    "summary": "Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller obesity-focused company.",
    "url": "https://www.investors.com/news/technology/pfizer-novo-nordisk-metsera-lawsuit/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e69fa08e-9a63-3f8c-80cb-567d1560374a",
      "content": {
        "id": "e69fa08e-9a63-3f8c-80cb-567d1560374a",
        "contentType": "STORY",
        "title": "Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal",
        "description": "",
        "summary": "Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller obesity-focused company.",
        "pubDate": "2025-10-31T21:26:53Z",
        "displayTime": "2025-10-31T21:26:53Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e69fa08e-9a63-3f8c-80cb-567d1560374a/pfizer-sues-novo-nordisk-and.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fsBKs1ZYBb29b_f6IZRvqg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SXW42BXOwOtnaZcm_tlLlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/pfizer-novo-nordisk-metsera-lawsuit/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T20:37:00+00:00",
    "headline": "Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement",
    "summary": "NEW YORK, October 31, 2025--Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit asserts claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metsera’s breach of its obligations under the merger agreement between Pfizer and Metsera.",
    "url": "https://finance.yahoo.com/news/pfizer-files-lawsuit-against-metsera-203700150.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "d80d1007-7669-38be-9cc9-47d0a9f3bbc9",
      "content": {
        "id": "d80d1007-7669-38be-9cc9-47d0a9f3bbc9",
        "contentType": "STORY",
        "title": "Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement",
        "description": "",
        "summary": "NEW YORK, October 31, 2025--Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit asserts claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metsera’s breach of its obligations under the merger agreement between Pfizer and Metsera.",
        "pubDate": "2025-10-31T20:37:00Z",
        "displayTime": "2025-10-31T20:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/62ab5f9933de9e706214a7e4fca2f8dc",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TuDy2.Ze7zABaIocd07Niw--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/62ab5f9933de9e706214a7e4fca2f8dc.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PUD9fdffRqTCNDQP11CCGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/62ab5f9933de9e706214a7e4fca2f8dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-files-lawsuit-against-metsera-203700150.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-files-lawsuit-against-metsera-203700150.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T19:50:00+00:00",
    "headline": "Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition",
    "summary": "NEW YORK, October 31, 2025--Pfizer Inc. (NYSE: PFE) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"), with respect to Pfizer’s pending acquisition of Metsera (NASDAQ: MTSR).",
    "url": "https://finance.yahoo.com/news/pfizer-receives-early-clearance-u-195000773.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "9da34f7e-4517-3e98-a5b8-dd7859407852",
      "content": {
        "id": "9da34f7e-4517-3e98-a5b8-dd7859407852",
        "contentType": "STORY",
        "title": "Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition",
        "description": "",
        "summary": "NEW YORK, October 31, 2025--Pfizer Inc. (NYSE: PFE) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the \"HSR Act\"), with respect to Pfizer’s pending acquisition of Metsera (NASDAQ: MTSR).",
        "pubDate": "2025-10-31T19:50:00Z",
        "displayTime": "2025-10-31T19:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/ee76be16da0a423a836edfe4a50415b6",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GuleX8KcXePpUvFoSMtHMQ--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ee76be16da0a423a836edfe4a50415b6.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KBMmGWL6Qog2URRWht8RRQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ee76be16da0a423a836edfe4a50415b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-receives-early-clearance-u-195000773.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-receives-early-clearance-u-195000773.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T19:18:55+00:00",
    "headline": "Market Chatter: Pfizer Could Use White House Connections to Counter Novo Nordisk's Bid for Metsera",
    "summary": "Pfizer (PFE) could leverage its White House connections to counter Novo Nordisk's (NVO) bid for obes",
    "url": "https://finance.yahoo.com/news/market-chatter-pfizer-could-white-191855319.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0cca1c53-f754-3935-a095-a612a70a9e17",
      "content": {
        "id": "0cca1c53-f754-3935-a095-a612a70a9e17",
        "contentType": "STORY",
        "title": "Market Chatter: Pfizer Could Use White House Connections to Counter Novo Nordisk's Bid for Metsera",
        "description": "",
        "summary": "Pfizer (PFE) could leverage its White House connections to counter Novo Nordisk's (NVO) bid for obes",
        "pubDate": "2025-10-31T19:18:55Z",
        "displayTime": "2025-10-31T19:18:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-pfizer-could-white-191855319.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-pfizer-could-white-191855319.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T16:36:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Eli Lilly, Novo Nordisk, Pfizer and more in the latest Market Talks covering Health Care.",
    "url": "https://www.wsj.com/health/pharma/health-care-roundup-market-talk-01d6e54d?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "698bdb7f-aa47-3be7-b727-7d49c6baf5df",
      "content": {
        "id": "698bdb7f-aa47-3be7-b727-7d49c6baf5df",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "Find insight on Eli Lilly, Novo Nordisk, Pfizer and more in the latest Market Talks covering Health Care.",
        "pubDate": "2025-10-31T16:36:00Z",
        "displayTime": "2025-10-31T16:36:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/698bdb7f-aa47-3be7-b727-7d49c6baf5df/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrhZrzCfqtmt.BmE13YeQA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OE1vcNqqSRZ1WIBYKKRlWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/health-care-roundup-market-talk-01d6e54d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T15:07:00+00:00",
    "headline": "Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?",
    "summary": "Pfizer's Q3 results are due on Nov. 4, with analysts eyeing $16.6B in sales and EPS of 66 cents as investors weigh the stock's next move.",
    "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-loom-buy-150700722.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "809b35a5-c503-3cbc-ad5b-beef2315ad2a",
      "content": {
        "id": "809b35a5-c503-3cbc-ad5b-beef2315ad2a",
        "contentType": "STORY",
        "title": "Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?",
        "description": "",
        "summary": "Pfizer's Q3 results are due on Nov. 4, with analysts eyeing $16.6B in sales and EPS of 66 cents as investors weigh the stock's next move.",
        "pubDate": "2025-10-31T15:07:00Z",
        "displayTime": "2025-10-31T15:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-loom-buy-150700722.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-loom-buy-150700722.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T14:46:00+00:00",
    "headline": "AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.",
    "summary": "AbbVie  stock dropped Friday after the biopharmaceutical company reported mixed results across its drug portfolios in the third quarter.  Shares declined 4.7% to $217.50, putting AbbVie on pace for its lowest same-day percentage decrease since May 14, according to Dow Jones Market Data.  Pharma peers traded mixed: Johnson & Johnson fell slightly while Pfizer gained 0.7%.",
    "url": "https://www.barrons.com/articles/abbvie-earnings-stock-price-15008c13?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "1b4fb55c-0c72-3999-8f43-ebf72aff93f1",
      "content": {
        "id": "1b4fb55c-0c72-3999-8f43-ebf72aff93f1",
        "contentType": "STORY",
        "title": "AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.",
        "description": "",
        "summary": "AbbVie  stock dropped Friday after the biopharmaceutical company reported mixed results across its drug portfolios in the third quarter.  Shares declined 4.7% to $217.50, putting AbbVie on pace for its lowest same-day percentage decrease since May 14, according to Dow Jones Market Data.  Pharma peers traded mixed: Johnson & Johnson fell slightly while Pfizer gained 0.7%.",
        "pubDate": "2025-10-31T14:46:00Z",
        "displayTime": "2025-10-31T14:46:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1b4fb55c-0c72-3999-8f43-ebf72aff93f1/abbvie-beats-third-quarter.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AUMQE6rlIPt4dCGUiOs_Xw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sc5SyCgfIAZl0d2DyWRqwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abbvie-earnings-stock-price-15008c13?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T14:28:06+00:00",
    "headline": "Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs",
    "summary": "<body><p>STORY: :: Novo Nordisk&nbsp;</p><p>Novo Nordisk has almost completed notifying employees impacted by the drugmaker's 9,000 job cuts.</p><p>That’s according to a LinkedIn post by CEO Mike Doustdar Friday.&nbsp;</p><p>As jobs were slashed globally, he added that the pace of informing people varied according to local laws.&nbsp;</p><p>It’s part of Doustdar’s restructuring drive which he launched last month.&nbsp;</p><p>And comes as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.</p><p>The $150 billion weight-loss drug market is booming and Novo’s setting its sights on newer heights. &nbsp;</p><p>:: Pfizer&nbsp;</p><p>The Danish pharma giant and another major rival Pfizer are in a bidding war over obesity biotech Metsera’s hottest experimental treatments.&nbsp;</p><p>The drugmakers are vying for access to its once-monthly GLP-1 injectable.</p><p>Current popular injectables, including Novo’s Wegovy and Eli Lilly’s Zepbound, are weekly shots.&nbsp;</p><p>Metsera is one of several companies developing experimental weight-loss drugs.</p><p>The move signals an aggressive turn by Novo Nordisk a week after the ousting of most of the company's board.</p><p>That was over concerns it was not moving fast enough in the obesity market.</p></body>",
    "url": "https://finance.yahoo.com/video/novo-nordisk-cuts-9-000-142806639.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "95ab028b-0f08-391b-9576-5330e1d275c7",
      "content": {
        "id": "95ab028b-0f08-391b-9576-5330e1d275c7",
        "contentType": "VIDEO",
        "title": "Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs",
        "description": "<title><body><p>STORY: :: Novo Nordisk </p><p>Novo Nordisk has almost completed notifying employees impacted by the drugmaker's 9,000 job cuts.</p><p>That’s according to a LinkedIn post by CEO Mike Doustdar Friday. </p><p>As jobs were slashed globally, he added that the pace of informing people varied according to local laws. </p><p>It’s part of Doustdar’s restructuring drive which he launched last month. </p><p>And comes as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.</p><p>The $150 billion weight-loss drug market is booming and Novo’s setting its sights on newer heights.  </p><p>:: Pfizer </p><p>The Danish pharma giant and another major rival Pfizer are in a bidding war over obesity biotech Metsera’s hottest experimental treatments. </p><p>The drugmakers are vying for access to its once-monthly GLP-1 injectable.</p><p>Current popular injectables, including Novo’s Wegovy and Eli Lilly’s Zepbound, are weekly shots. </p><p>Metsera is one of several companies developing experimental weight-loss drugs.</p><p>The move signals an aggressive turn by Novo Nordisk a week after the ousting of most of the company's board.</p><p>That was over concerns it was not moving fast enough in the obesity market.</p></body></title>",
        "summary": "<body><p>STORY: :: Novo Nordisk&nbsp;</p><p>Novo Nordisk has almost completed notifying employees impacted by the drugmaker's 9,000 job cuts.</p><p>That’s according to a LinkedIn post by CEO Mike Doustdar Friday.&nbsp;</p><p>As jobs were slashed globally, he added that the pace of informing people varied according to local laws.&nbsp;</p><p>It’s part of Doustdar’s restructuring drive which he launched last month.&nbsp;</p><p>And comes as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.</p><p>The $150 billion weight-loss drug market is booming and Novo’s setting its sights on newer heights. &nbsp;</p><p>:: Pfizer&nbsp;</p><p>The Danish pharma giant and another major rival Pfizer are in a bidding war over obesity biotech Metsera’s hottest experimental treatments.&nbsp;</p><p>The drugmakers are vying for access to its once-monthly GLP-1 injectable.</p><p>Current popular injectables, including Novo’s Wegovy and Eli Lilly’s Zepbound, are weekly shots.&nbsp;</p><p>Metsera is one of several companies developing experimental weight-loss drugs.</p><p>The move signals an aggressive turn by Novo Nordisk a week after the ousting of most of the company's board.</p><p>That was over concerns it was not moving fast enough in the obesity market.</p></body>",
        "pubDate": "2025-10-31T14:28:06Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/vACYeKq8PNcBreSBSqe5jw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/6ccc1ada-4955-4aa1-aa40-894506d7a30d/main/1280x720/36s661ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nB3marT5EZkNv7x3TYYYnA--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/6ccc1ada-4955-4aa1-aa40-894506d7a30d/main/1280x720/36s661ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DZbeyiKnTfkhrKyWOOhWgg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/6ccc1ada-4955-4aa1-aa40-894506d7a30d/main/1280x720/36s661ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/novo-nordisk-cuts-9-000-142806639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/novo-nordisk-cuts-9-000-142806639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T14:03:06+00:00",
    "headline": "Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War",
    "summary": "We recently published 10 Stocks with Outstanding Gains; 9 on Record Highs. Metsera Inc. (NASDAQ:MTSR) is one of the best-performing stocks on Thursday. Metsera rallied to a fresh all-time high on Thursday, as investor optimism was bolstered by a billion-dollar bidding war between pharmaceutical giants Pfizer Inc. and Novo Nordisk. In intra-day trading, Metsera Inc. […]",
    "url": "https://finance.yahoo.com/news/metsera-mtsr-soars-time-high-140306433.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "3fad3620-0012-34e3-845a-7c8f3df221ea",
      "content": {
        "id": "3fad3620-0012-34e3-845a-7c8f3df221ea",
        "contentType": "STORY",
        "title": "Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War",
        "description": "",
        "summary": "We recently published 10 Stocks with Outstanding Gains; 9 on Record Highs. Metsera Inc. (NASDAQ:MTSR) is one of the best-performing stocks on Thursday. Metsera rallied to a fresh all-time high on Thursday, as investor optimism was bolstered by a billion-dollar bidding war between pharmaceutical giants Pfizer Inc. and Novo Nordisk. In intra-day trading, Metsera Inc. […]",
        "pubDate": "2025-10-31T14:03:06Z",
        "displayTime": "2025-10-31T14:03:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4a858fbacfbf4b642250d493784b980a",
          "originalWidth": 1280,
          "originalHeight": 820,
          "caption": "Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iF44cR9BKOGSwfl5aZ6hjw--~B/aD04MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4a858fbacfbf4b642250d493784b980a.cf.webp",
              "width": 1280,
              "height": 820,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MTbIy8.rV_MR88xxnfX70g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4a858fbacfbf4b642250d493784b980a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-mtsr-soars-time-high-140306433.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-mtsr-soars-time-high-140306433.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T12:25:08+00:00",
    "headline": "Pfizer Faces Off With Novo Nordisk Over Metsera Bid",
    "summary": "U.S. drugmaker may leverage political ties as takeover battle intensifies",
    "url": "https://finance.yahoo.com/news/pfizer-faces-off-novo-nordisk-122508609.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "228a8536-7211-3ae4-8966-ae37963a05f6",
      "content": {
        "id": "228a8536-7211-3ae4-8966-ae37963a05f6",
        "contentType": "STORY",
        "title": "Pfizer Faces Off With Novo Nordisk Over Metsera Bid",
        "description": "",
        "summary": "U.S. drugmaker may leverage political ties as takeover battle intensifies",
        "pubDate": "2025-10-31T12:25:08Z",
        "displayTime": "2025-10-31T12:25:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vu.kxzmN7yCA.wz8Cs.cHg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Brb0J12XOUXl4lathAg3vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-faces-off-novo-nordisk-122508609.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-faces-off-novo-nordisk-122508609.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T10:30:00+00:00",
    "headline": "Eli Lilly’s Sterling Results Highlight Rival Novo Nordisk’s Fading Fortunes",
    "summary": "Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.",
    "url": "https://www.thedailyupside.com/industries/healthcare/eli-lillys-sterling-results-come-as-fading-rival-novo-nordisk-seeks-reset/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "881c37a3-3846-3c35-880b-444bd5e2885a",
      "content": {
        "id": "881c37a3-3846-3c35-880b-444bd5e2885a",
        "contentType": "STORY",
        "title": "Eli Lilly’s Sterling Results Highlight Rival Novo Nordisk’s Fading Fortunes",
        "description": "",
        "summary": "Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.",
        "pubDate": "2025-10-31T10:30:00Z",
        "displayTime": "2025-10-31T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/0877260d80a351d8feb60f3dea9b6f8a",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "A person's hands are shown handling a does of GLPT-1 drug Mounjaro, which is manufactured by Eli Lilly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WZ_oD49Yd64eskq0rSsnCA--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/0877260d80a351d8feb60f3dea9b6f8a.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NdqllhIae9vkhp79r7wppg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/0877260d80a351d8feb60f3dea9b6f8a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/eli-lillys-sterling-results-come-as-fading-rival-novo-nordisk-seeks-reset/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-sterling-results-highlight-103000160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "CMG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T06:00:21+00:00",
    "headline": "Stocks to watch next week: Palantir, Advanced Micro Devices, Uber, Novo Nordisk and BP",
    "summary": "Earnings preview of key companies reporting in the coming week and what to look out for.",
    "url": "https://uk.finance.yahoo.com/news/palantir-advanced-micro-devices-uber-novo-nordisk-bp-stocks-to-watch-060021355.html",
    "source": "Yahoo Finance UK",
    "provider": "yfinance",
    "raw": {
      "id": "0add74fd-700c-45a9-858e-e4bee4b3ba58",
      "content": {
        "id": "0add74fd-700c-45a9-858e-e4bee4b3ba58",
        "contentType": "STORY",
        "title": "Stocks to watch next week: Palantir, Advanced Micro Devices, Uber, Novo Nordisk and BP",
        "description": "",
        "summary": "Earnings preview of key companies reporting in the coming week and what to look out for.",
        "pubDate": "2025-10-31T06:00:21Z",
        "displayTime": "2025-10-31T06:00:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/fa7628b0-b5ae-11f0-af7f-714e4cd86fb3",
          "originalWidth": 5291,
          "originalHeight": 3527,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/doViwa5gYtVU2fMgdIfVZw--~B/aD0zNTI3O3c9NTI5MTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/fa7628b0-b5ae-11f0-af7f-714e4cd86fb3.cf.webp",
              "width": 5291,
              "height": 3527,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JOLoyB7RbqUD3yZ2NGvfqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/fa7628b0-b5ae-11f0-af7f-714e4cd86fb3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance UK",
          "url": "http://uk.finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/palantir-advanced-micro-devices-uber-novo-nordisk-bp-stocks-to-watch-060021355.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/palantir-advanced-micro-devices-uber-novo-nordisk-bp-stocks-to-watch-060021355.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "BP.L"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T02:30:14+00:00",
    "headline": "Jim Cramer on Pfizer: “The Drug Stocks Are Just in a World of Hurt, and This One Continues to Be There”",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently talked about. During the lightning round, when a caller asked about the stock, Cramer commented: “I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to change it. But […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-pfizer-drug-stocks-023014881.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "00f9bf08-8e3f-3696-be36-166ef9f9a7c0",
      "content": {
        "id": "00f9bf08-8e3f-3696-be36-166ef9f9a7c0",
        "contentType": "STORY",
        "title": "Jim Cramer on Pfizer: “The Drug Stocks Are Just in a World of Hurt, and This One Continues to Be There”",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently talked about. During the lightning round, when a caller asked about the stock, Cramer commented: “I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to change it. But […]",
        "pubDate": "2025-10-31T02:30:14Z",
        "displayTime": "2025-10-31T02:30:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c",
          "originalWidth": 1920,
          "originalHeight": 1272,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lBNvOkwEcDTC6JSi8u6u5Q--~B/aD0xMjcyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 1920,
              "height": 1272,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l4R272WQ4gg_U7DbC5QzrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-pfizer-drug-stocks-023014881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-pfizer-drug-stocks-023014881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]